Airing weekdays at 7:30 A.M. on

Airing weekdays at 7:30 A.M. on


Media Contact
(844) 200-2525


Valeritas, Inc., Advance Auto Parts and Sobi take center stage on March 24, 2016 on Lifetime®.

(DEERFIELD BEACH, Fla. – PR LOG – March 23, 2016) The Balancing Act® welcomes experts on insulin delivery methods, fighting Type 1 Diabetes and a rare childhood disease, Thursday, March 24 and March 31, 2016 at 7:30 a.m. (ET/PT) on Lifetime®.

Don’t miss these special guests on The Balancing Act:


Revolutionizing Insulin Delivery Methods – with Valeritas, Inc.

More than 70% of the thousands of patients with Type 2 Diabetes on multiple insulin injections don’t take their insulin away from home. For dedicated clinicians like Physician’s Assistant and Certified Diabetes Educator, John Sink, watching these patients struggle with managing their diabetes has been a constant challenge. Existing delivery methods are time consuming, don’t always lower glucose numbers and negatively affect patients’ lifestyles. In 2012, Valeritas introduced V-Go®: a revolution in Type 2 Diabetes care. It is a wearable, disposable insulin delivery device that allows delivery of both a background rate of insulin for 24 hours, and on-demand dosing at mealtimes and snacks. You apply the small adhesive device discreetly under your clothing, click a few buttons throughout the day and simply replace it every 24 hours. Joining The Balancing Act, John Sink and one of his patients explain the innovative way this tiny device is helping patients enjoy their lives, while simultaneously delivering improved blood glucose numbers and A1C levels with less injections. Visit


Finding a Cure for Type 1 Diabetes – with Advance Auto Parts

With more than 5,200 company-operated stores in the United States, Puerto Rico, the U.S. Virgin Islands and Canada, Advance Auto Parts, Inc. is one of the nation’s leading automotive aftermarket parts providers. The company is also one of the largest supporters in the fight to cure Type 1 Diabetes (T1D). Since 1994, Advance Auto Parts has raised more than $41 million in support of JDRF (formerly Juvenile Diabetes Research Foundation), whose mission is to accelerate life-changing breakthroughs to cure, prevent and treat T1D and its complications. JDRF is the leading global organization funding T1D research. Advance Auto Parts has been involved in the fight for more than 20 years, but recently, the partnership has become even more personal: not long ago, Advance’s Chief Financial Officer, Mike Norona, announced his own son suffers from T1D. Go to to learn more about Advance Auto Parts.


Fighting a Rare Childhood Disease – with Sobi

If there was a disease out there so rare that only about 40 people in the entire country were affected, would it still be worth fighting? According to Colleen Paduani, and the parents of any of the other 39 or so patients, the answer is a resounding yes.  On this special episode of The Balancing Act, Behind the Mystery: Rare and Genetic Diseases, 8-year-old Quinn Paduani shares her journey with the Ultra-Rare Orphan disease called NOMID, along with Dr. Philip Kahn, Pediatric Rheumatologist, who talks about the importance of early diagnosis. It all starts with knowing the signs, symptoms and resources connected with this rarest of rare auto-inflammatory diseases. For more information, visit


About The Balancing Act®

Entering its 8th season, The Balancing Act continues to empower women in all aspects of their lives. The mission at The Balancing Act is simple – to help today’s modern woman balance it all by bringing them positive solutions to enrich and empower them. Entertaining, educational and trusted by women, viewers can tune in to America’s premier morning show The Balancing Act on weekday mornings, Monday through Friday, at 7:30 a.m. (ET/PT) on Lifetime television. For additional information or to view a segment, visit:


Join the Conversation!

Like us on Facebook at:

Follow us on Twitter at:

Watch us on YouTube at:

Health, Wealth, Beauty, and Business

Bringing the best tips from the experts in Atlanta in business, beauty, wealth management, child healthcare, car shopping, and more. Each year, Atlanta’s Women’s Entrepreneurship Initiative selects 15 local female entrepreneurs for a 15-month business training program. We meet women who have grown their companies, created jobs, and broke through the glass ceiling. With some […]

iMCD is the deadliest subtype of Castleman disease. Approximately one third of patients die within five years of diagnosis, and another third die within 10 years if not treated.

There are no effective treatment options for people with unresectable or metastatic chondrosarcoma despite many attempts by multiple pharmaceutical companies over the past few decades.